Scientific Breakthrough: We Can Now Halve the Price of Costly Cancer Drug
5 Articles
5 Articles
Scientific breakthrough: We can now halve the price of costly cancer drug
The demand for the widely used cancer drug Taxol is increasing, but it's difficult and expensive to produce because it hasn't been possible to do it biosynthetically. Until now, that is. Researchers have now cracked the last part of a code that science has struggled with for 30 years. The breakthrough could halve the price of the drug and make production far more sustainable.
Biosynthetic advance could halve the cost of widely used cancer drug
The demand for the widely used cancer drug Taxol is increasing, but it's difficult and expensive to produce because it hasn't been possible to do it biosynthetically. Until now, that is. Researchers from the University of Copenhagen have cracked the last part of a code that science has struggled with for 30 years. The breakthrough could halve the price of the drug and make production far more sustainable.
University of Copenhagen Researchers Unveil Biosynthetic Method to Cut the Cost of Taxol and Make Production More Sustainable
University of Copenhagen Researchers Unveil Biosynthetic Method to Cut the Cost of Taxol and Make Production More Sustainable (IN BRIEF) Researchers from the University of Copenhagen have made a breakthrough in the biosynthetic production of Taxol, a widely used chemotherapy drug. By identifying the enzymes responsible for the final steps in the biosynthetic pathway of Taxol, the team has developed a method that enables the drug to be produced i…
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage